Anil Raghavan
-
SPARC in agreement with Johns Hopkins University and IOCB for SCD-153
SCD-153 is the first-in-class topical formulation for the treatment of Alopecia Areata Sun Pharma Advanced Research Company has entered into…
Read More » -
SPARC posts positive clinical trial result for SDN-037
Sun Pharma Advanced Research Company (SPARC) has reported positive top-line results from its Phase III trial for its investigational drug,…
Read More »